Research suggests the benefits of testosterone therapy after prostate cancer surgery in select men may outweigh risks.

Cuts to Medicare physician reimbursement have taken effect, as proposed legislation intended to eliminate those cuts did not pass.

(HealthDay News) — Interstitial cystitis and bladder pain syndrome (IC/BPS) vary in clinical manifestation, according to a study published online in the International Journal of Urology.

Adverse events were frequent, and most were gastrointestinal-related, including nausea, vomiting, diarrhea, constipation ...

The clinical nurse specialist in uro-oncology is undervalued and underdeveloped, according to a discussion paper on the role of this clinician.

(HealthDay News) — Patient-centered pathology reports (PCPR) help patients to understand prostate cancer results better than current standard format reports, according to a research letter published ...

Fewer punctures and shorter surgical time reported for sacral neuromodulation with 3D printing and ultrasound localization ...

No dedicated clinical trials have compared denosumab and bisphosphonates for fracture prevention in patients on dialysis.

Doctor apology is an important part of an adverse event disclosure process designed to help heal the treatment relationship when a patient feels they have been wronged.

Evidence linking alcohol to cancer has accumulated for years, yet less than half of Americans recognize it as a cancer risk factor ...

(HealthDay News) — Racial and ethnic disparities are seen in the use of obesity-management medications, according to a study published online in the Journal of Racial and Ethnic Health Disparities.

Participation in the 340B Drug Pricing Program does not increase the use of targeted therapy in older patients with advanced prostate cancer, a study suggests.